Validus Pharmaceuticals, Inc. is recalling approximately 8,560 bottles of Calcitriol and Rocaltrol (calcitriol) Oral Solutions (1 mcg/mL, 15 mL bottles). These prescription medications used to treat calcium and parathyroid hormone levels were found to have lower than expected potency during stability testing. Consumers should be aware that taking subpotent medication may result in ineffective treatment for their condition.
A lower than expected potency means the medication may not provide the full therapeutic dose required by the patient, potentially leading to poorly controlled calcium levels or other related medical issues. No specific incidents or injuries have been reported to date.
Pharmacy refund and healthcare consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.